Optimizing Diagnostics: The Synergy of AI Integration with Tribun Health and Ibex

Learn how Tribun Health and Ibex are integrating AI-powered digital pathology to improve diagnoses, streamline workflows, and support pathologists globally.

Artificial intelligence is gradually becoming a practical tool for healthcare, offering solutions to some of the most persistent challenges in the field. AI in pathology is one area that is seeing significant benefits: the technology is helping pathologists manage increasing workloads while improving diagnostic accuracy and efficiency.

At Carrefour Pathologie 2024, Tribun Health and Ibex shared how they are integrating AI-powered digital pathology into routine practice. In a session titled “Optimizing Diagnostics: Integrating AI with Tribun Health and Ibex,” Celine Riou , AI Product Manager at Tribun Health, and Dr. Geraldine Sebag , Pathologist at Ibex, presented real-world applications of these tools and the significant impact they are having on diagnostic workflows.

The power of digital pathology with Tribun Health

Tribun Health has created a platform that doesn’t just digitize pathology, but optimizes every aspect of the process. Their flagship product, CaloPix ® , seamlessly integrates into existing lab workflows to support image management, annotation, and long-term storage. What sets it apart is its ability to incorporate third-party AI algorithms, giving labs of all sizes access to cutting-edge tools like Ibex’s.

The Tribun Health platform is web-based, secure, and approved for use in multiple markets. With connectivity at its core, CaloPix ® is designed to adapt to labs’ specific needs while ensuring scalability for future growth.

Ibex: Redefining precision in pathology using AI

Dr. Sebag demonstrated how Ibex’s AI-powered tools augment the diagnostic process while maintaining the central role of pathologists. Ibex’s solutions address modern challenges such as the pathologist shortage, increasing cancer incidence, and diagnostic complexity.

Designed “by pathologists for pathologists,” Ibex leverages over 10 million annotated slides to deliver exceptional accuracy and efficiency. Its algorithms, validated through extensive studies, demonstrate remarkable improvements in workflow optimization, diagnostic accuracy, and reduced turnaround times. Whether identifying prostate cancer, classifying Gleason scores, or detecting gastric cancer biomarkers, Ibex is setting a new benchmark in pathology.

Integration for better diagnosis

The integration of AI algorithms into CaloPix® offers unparalleled advantages:

• Case Prioritization: Smart menus and real-time alerts ensure urgent cases are handled first.
• Comprehensive Analysis: AI-driven heatmaps highlight cancerous and non-cancerous morphologies with advanced classification support .
• User-friendly interfaces: Pathologists navigate with ease through intuitive tools tailored to their needs.
• Workflow Optimization: Automated quality control, biomarker scoring, and predictive insights streamline lab operations.

This collaboration extends to various types of cancer, including prostate, breast and gastric cancers. For example, Ibex’s solution for gastric cancer not only detects high-grade lesions, but also identifies H. Pylori, reducing the need for additional staining methods.

The Future of Pathology

Tribun Health and Ibex are bringing to life the synergy of AI and human expertise, driving a transformative change in the field of pathology. By reducing diagnostic errors, increasing reproducibility, and supporting pathologists in their decision-making, these innovations are dramatically improving patient care.

As Dr. Sebag rightly pointed out, “ AI does not replace the pathologist, it guides and assists them, ensuring diagnostic accuracy and efficiency.”

SOURCE: Tribun Health